VEGF regulates local inhibitory complement proteins in the eye and kidney

Keir, L; Firth, R; Aponik, L; Feitelberg, D; Sakimoto, S; Aguilar, E; Welsh, G; Richards, A; Usui, Y; Satchell, S; Kuzmuk, V; Coward, R; Goult, J; Bull, K; Sharma, R; Bharti, K; Westenskow, P; Michael, I; Saleem, M; Friedlander, M

Journal article

VEGF regulates local inhibitory complement proteins in the eye and kidney

Abstract:: Outer retinal and renal glomerular functions rely on specialized vasculature maintained by VEGF that is produced by neighboring epithelial cells, the retinal pigment epithelium (RPE) and podocytes, respectively. Dysregulation of RPE- and podocyte-derived VEGF is associated with neovascularization in wet age-related macular degeneration (ARMD), choriocapillaris degeneration, and glomerular thrombotic microangiopathy (TMA). Since complement activation and genetic variants in inhibitory complement factor H (CFH) are also features of both ARMD and TMA, we hypothesized that VEGF and CFH interact. Here, we demonstrated that VEGF inhibition decreases local CFH and other complement regulators in the eye and kidney through reduced VEGFR2/PKC-α/CREB signaling. Patient podocytes and RPE cells carrying disease-associated CFH genetic variants had more alternative complement pathway deposits than controls. These deposits were increased by VEGF antagonism, a common wet ARMD treatment, suggesting that VEGF inhibition could reduce cellular complement regulatory capacity. VEGF antagonism also increased markers of endothelial cell activation, which was partially reduced by genetic complement inhibition. Together, these results suggest that VEGF protects the retinal and glomerular microvasculature, not only through VEGFR2-mediated vasculotrophism, but also through modulation of local complement proteins that could protect against complement-mediated damage. Though further study is warranted, these findings could be relevant for patients receiving VEGF antagonists.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Keir, L., Firth, R., Aponik, L., Feitelberg, D., Sakimoto, S., Aguilar, E., Welsh, G., Richards, A., Usui, Y., Satchell, S., Kuzmuk, V., Coward, R., Goult, J., Bull, K., Sharma, R., Bharti, K., Westenskow, P., Michael, I., Saleem, M., & Friedlander, M. (2016). VEGF regulates local inhibitory complement proteins in the eye and kidney. Journal of Clinical Investigation, 127(1), 199–214.

MLA Style

Keir, L., et al. “VEGF Regulates Local Inhibitory Complement Proteins in the Eye and Kidney.” Journal of Clinical Investigation, vol. 127, no. 1, American Society for Clinical Investigation, 2016, pp. 199–214.

Chicago Style

Keir, L, R Firth, L Aponik, D Feitelberg, S Sakimoto, E Aguilar, G Welsh, et al. 2016. “VEGF Regulates Local Inhibitory Complement Proteins in the Eye and Kidney.” Journal of Clinical Investigation 127 (1): 199–214.
Share
Print